Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ants Toi

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancerChris Parker, Michael Milosevic, Ants Toi, et al.
Prenatal Diagnosis|July 10, 2013
Dyssegmental dysplasia, Silverman-Handmaker type: prenatal ultrasound findings and molecular analysisNoor Niyar N Ladhani, David Chitayat, Marjan M Nezarati, et al.
The Journal of Urology|March 7, 2006
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosisRobert K Nam, Jonathan R Reeves, Ants Toi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohortAmar Bhindi, Bimal Bhindi, Girish S Kulkarni, et al.
The Journal of Urology|July 27, 2016
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active SurveillanceNathan Perlis, Rashid Sayyid, Andrew Evans, et al.
Prenatal Diagnosis|May 5, 2010
Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER studyAndrew R MacRae, Bernie N Chodirker, Gregory A Davies, et al.
Prenatal Diagnosis|December 12, 2018
Fetal myelomeningocele surgery: Only treating the tip of the icebergAlyaa AlRefai, James Drake, Abhaya V Kulkarni, et al.
The Journal of Molecular Diagnostics : JMD|October 13, 2019
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer PatientsAndrea J Savio, Shivani Kamdar, Renu Jeyapala, et al.
BJU International|March 1, 2012
Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancerBimal Bhindi, Greg Trottier, Malik Elharram, et al.
The Canadian Journal of Urology|May 5, 2006
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancerChris Parker, Michael Milosevic, Ants Toi, et al.
Prenatal Diagnosis|July 10, 2013
Dyssegmental dysplasia, Silverman-Handmaker type: prenatal ultrasound findings and molecular analysisNoor Niyar N Ladhani, David Chitayat, Marjan M Nezarati, et al.
The Journal of Urology|March 7, 2006
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosisRobert K Nam, Jonathan R Reeves, Ants Toi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohortAmar Bhindi, Bimal Bhindi, Girish S Kulkarni, et al.
The Journal of Urology|July 27, 2016
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active SurveillanceNathan Perlis, Rashid Sayyid, Andrew Evans, et al.
Prenatal Diagnosis|May 5, 2010
Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER studyAndrew R MacRae, Bernie N Chodirker, Gregory A Davies, et al.
Prenatal Diagnosis|December 12, 2018
Fetal myelomeningocele surgery: Only treating the tip of the icebergAlyaa AlRefai, James Drake, Abhaya V Kulkarni, et al.
The Journal of Molecular Diagnostics : JMD|October 13, 2019
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer PatientsAndrea J Savio, Shivani Kamdar, Renu Jeyapala, et al.
BJU International|March 1, 2012
Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancerBimal Bhindi, Greg Trottier, Malik Elharram, et al.
The Canadian Journal of Urology|May 5, 2006
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Pageof 11